| Aβ | Amyloid-β |
| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| AX | Astaxanthin |
| BBB | Blood–brain barrier |
| BD | Bipolar disorder |
| BDNF | Brain-derived neurotrophic factor |
| CBD | Cannabidiol |
| CGA | Chlorogenic acid |
| CNS | Central nervous system |
| COX-2 | Cyclooxygenase-2 |
| CREB | cAMP response element binding protein |
| DHA | Docosahexaenoic acid |
| EFAs | Essential fatty acids |
| EPA | Eicosapentaenoic acid |
| ERK | Extracellular signal-regulated kinase |
| FMT | Fecal microbiota transplantation |
| Gb | Ginkgo biloba |
| GBA | Gut–brain axis |
| GM | Gut microbiome |
| GPR55 | G-protein-coupled receptor 55 |
| 5-HT1A | Serotonin 1A receptor |
| iNOS | Inducible nitric oxide synthase |
| KRG | Korean red ginseng |
| LPS | Lipopolysaccharides |
| 5-LOX | 5-lipoxygenase |
| MAPK | Mitogen-activated protein kinase |
| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| MDD | Major depressive disorder |
| NMDA | N-methyl-D-aspartate |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| Nrf2/HO-1 | Nuclear factor erythroid 2-related factor 2/heme oxygenase-1 |
| omega-3 PUFAs | Omega-3 polyunsaturated fatty acids |
| omega-6 PUFAs | Omega-6 polyunsaturated fatty acids |
| PD | Parkinson’s disease |
| PKA | Protein kinase A |
| PKB | Protein kinase B |
| PPAR | Peroxisome proliferator-activated receptor |
| PPD | Protopanaxadiol |
| PPT | Protopanaxatriol |
| RCTs | Randomized clinical trials |
| ROS | Reactive oxygen species |
| SCFAs | Short-chain fatty acids |
| TDP-43 | Trans-active response DNA-binding protein-43 |
| THC | Δ9-tetrahydrocannabinol |
| TNF-α | Tumor necrosis factor-α |
| TQ | Thymoquinone |
| TRPC6 | Transient receptor potential C6 |